» Articles » PMID: 34603293

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma

Overview
Journal Front Immunol
Date 2021 Oct 4
PMID 34603293
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, the molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) that drive HCC initiation and progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature in patients with HCC is still lacking. In this study, the association between differentially expressed lncRNAs and ferroptosis-related genes, in 374 HCC and 50 normal hepatic samples obtained from The Cancer Genome Atlas (TCGA), was evaluated using Pearson's test, thereby identifying 24 ferroptosis-related differentially expressed lncRNAs. The least absolute shrinkage and selection operator (LASSO) algorithm and Cox regression model were used to construct and validate a prognostic risk score model from both TCGA training dataset and GEO testing dataset (GSE40144). A nine-lncRNA-based signature (CTD-2033A16.3, CTD-2116N20.1, CTD-2510F5.4, DDX11-AS1, LINC00942, LINC01224, LINC01231, LINC01508, and ZFPM2-AS1) was identified as the ferroptosis-related prognostic model for HCC, independent of multiple clinicopathological parameters. In addition, the HCC patients were divided into high-risk and low-risk groups according to the nine-lncRNA prognostic signature. The gene set enrichment analysis enrichment analysis revealed that the lncRNA-based signature might regulate the HCC immune microenvironment by interfering with tumor necrosis factor α/nuclear factor kappa-B, interleukin 2/signal transducers and activators of transcription 5, and cytokine/cytokine receptor signaling pathways. The infiltrating immune cell subtypes, such as resting memory CD4(+) T cells, follicular helper T cells, regulatory T cells, and M0 macrophages, were all significantly different between the high-risk group and the low-risk group as indicated in Spearman's correlation analysis. Moreover, a substantial increase in the expression of B7H3 immune checkpoint molecule was found in the high-risk group. Our findings provided a promising insight into ferroptosis-related lncRNAs in HCC and a personalized prediction tool for prognosis and immune responses in patients.

Citing Articles

Subtype cluster analysis unveiled the correlation between m6A- and cuproptosis-related lncRNAs and the prognosis, immune microenvironment, and treatment sensitivity of esophageal cancer.

Zhang M, Su Y, Wen P, Shao X, Yang P, An P Front Immunol. 2025; 16:1539630.

PMID: 40034693 PMC: 11872909. DOI: 10.3389/fimmu.2025.1539630.


Cellular Membrane Protein GRINA is Highly Expressed and Associated with Survival Outcomes in Liver Cancer Patients.

Song J, Guo S, Gao W, Yang Z, Tian Z Curr Med Sci. 2025; 45(1):122-136.

PMID: 40011365 DOI: 10.1007/s11596-025-00025-3.


Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma.

Wu X, Liu B, Deng S, Xiong T, Dai L, Cheng B BMC Oral Health. 2025; 25(1):180.

PMID: 39894803 PMC: 11789412. DOI: 10.1186/s12903-024-05279-2.


Identification of PIF1 as a Ferroptosis-Related Prognostic Biomarker Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Liu F, Yin P, Lu L, Yao J, Jiao B Appl Biochem Biotechnol. 2025; .

PMID: 39888492 DOI: 10.1007/s12010-024-05161-5.


Integrative bioinformatics approach identifies novel drug targets for hyperaldosteronism, with a focus on SHMT1 as a promising therapeutic candidate.

Jia M, Lin L, Yu H, Dong Z, Pan X, Song X Sci Rep. 2025; 15(1):1690.

PMID: 39799159 PMC: 11724956. DOI: 10.1038/s41598-025-85900-8.


References
1.
Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

2.
Liu Y, Zhang X, Zhang J, Tan J, Li J, Song Z . Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma. Front Cell Dev Biol. 2021; 8:596679. PMC: 7785857. DOI: 10.3389/fcell.2020.596679. View

3.
He Y, Wang X . Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis. Ann Transl Med. 2020; 8(17):1050. PMC: 7575957. DOI: 10.21037/atm-20-922. View

4.
Pilones K, Hensler M, Daviaud C, Kraynak J, Fucikova J, Galluzzi L . Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade. Oncoimmunology. 2020; 9(1):1830524. PMC: 7583495. DOI: 10.1080/2162402X.2020.1830524. View

5.
Czerwinska P, Rucinski M, Wlodarczyk N, Jaworska A, Grzadzielewska I, Gryska K . Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6. Oncoimmunology. 2020; 9(1):1710063. PMC: 6959432. DOI: 10.1080/2162402X.2019.1710063. View